How we do it: whole lung lavage
Whole lung lavage
Keywords:
: Pulmonary alveolar proteinosis, bronchoscopy, bronchoalveolar lavage, diffuse parenchymal lung disease, interstitial lung diseaseAbstract
Pulmonary alveolar proteinosis (PAP) is a rare pulmonary disorder characterized by the accumulation of surfactant in the alveolar spaces resulting in hypoxemic respiratory failure. Whole lung lavage (WLL), the preferred treatment for PAP, physically removes the lipo-proteinaceous material from the alveolar spaces. Since its initial description in 1963, the WLL procedure has undergone various modifications. However, the procedure has not been standardized yet. After securing a double lumen endotracheal tube, we perform WLL under general anesthesia. One lung is ventilated, while the other is lavaged using one-liter aliquots of pre-warmed saline. We use gravity-assisted drainage of the lavaged lung after each cycle till the milky white and opaque fluid becomes clear (usually 15-20 cycles). Herein, we describe the step-by-step procedure, precautions, and monitoring of WLL. We also provide videos demonstrating one-lung ventilation and bronchoscopic confirmation of lung isolation.
Keywords: Pulmonary alveolar proteinosis; bronchoscopy; bronchoalveolar lavage; interstitial lung disease: diffuse parenchymal lung disease
References
Khan A, Agarwal R. Pulmonary alveolar proteinosis. Respir Care. 2011;56(7):1016-28.
Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. The New England journal of medicine. 1958;258(23):1123-42.
Ramirez J, Schultz RB, Dutton RE. Pulmonary Alveolar Proteinosis: A New Technique and Rationale for Treatment. Archives of internal medicine. 1963;112:419-31.
Ramirez J, Kieffer RF, Jr., Ball WC, Jr. Bronchopulmonary lavage in man. Ann Intern Med. 1965;63(5):819-28.
Shah PL, Hansell D, Lawson PR, Reid KB, Morgan C. Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis. Thorax. 2000;55(1):67-77.
Campo I, Luisetti M, Griese M, Trapnell BC, Bonella F, Grutters J, et al. Whole lung lavage therapy for pulmonary alveolar proteinosis: a global survey of current practices and procedures. Orphanet J Rare Dis. 2016;11(1):115.
Michaud G, Reddy C, Ernst A. Whole-lung lavage for pulmonary alveolar proteinosis. Chest. 2009;136(6):1678-81.
Khan A, Agarwal R, Aggarwal AN. Effectiveness of granulocyte-macrophage colony-stimulating factor therapy in autoimmune pulmonary alveolar proteinosis: a meta-analysis of observational studies. Chest. 2012;141(5):1273-83.
Trapnell BC, Inoue Y, Bonella F, Morgan C, Jouneau S, Bendstrup E, et al. Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis. N Engl J Med. 2020;383(17):1635-44.
Radpay B, Parsa T, Dabir S, Boloursaz M, Arbab A, Tabatabaei S. Whole Lung Lavage of Nine Children with Pulmonary Alveolar Proteinosis: Experience in a Tertiary Lung Center. Iranian Journal of Pediatrics. 2013;23(1):95-9.
Vymazal T, Krecmerova M. Respiratory Strategies and Airway Management in Patients with Pulmonary Alveolar Proteinosis: A Review. BioMed Research International.2015:1-5.
Ramachandran P, Chaudhury A, Devaraj U, Maheshwari K, D'Souza G. Monitoring whole-lung lavage using lung ultrasound: The changing phases of the lung. Lung India. 2018;35(4):350-3.
Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med. 2002;166(2):215-35.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Deepa Shreshta, Sahajal Dhooria, Ganesh Kumar Munirathinam, Inderpaul Singh Sehgal, Kuruswamy Thurai Prasad, Babu Ram, Harkant Singh, Ashutosh Nath Aggarwal, Goverdhan D Puri, Valliappan Muthu, Ritesh Agarwal

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.